Cargando…

A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families

Mammographic screening and prophylactic surgery such as risk-reducing salpingo oophorectomy can potentially reduce breast cancer risks among mutation carriers of BRCA families. The evaluation of these interventions is usually complicated by the fact that their effects on breast cancer may change ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yun-Hee, Jung, Hae, Buys, Saundra, Daly, Mary, John, Esther M, Hopper, John, Andrulis, Irene, Terry, Mary Beth, Briollais, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424615/ https://www.ncbi.nlm.nih.gov/pubmed/34232831 http://dx.doi.org/10.1177/09622802211008945

Ejemplares similares

Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)
por: Terry, Mary Beth, et al.
Publicado: (2016)

Rare variants in the ATM gene and risk of breast cancer
por: Goldgar, David E, et al.
Publicado: (2011)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
por: Terry, Mary Beth, et al.
Publicado: (2018)

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
por: Whittemore, A S, et al.
Publicado: (2004)

Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry
por: Smith, Letitia D, et al.
Publicado: (2011)

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab
por: Li, Hongyan, et al.
Publicado: (2016)

Non-invasive optical spectroscopic monitoring of breast development during puberty
por: Lilge, Lothar, et al.
Publicado: (2017)

Missing covariates in competing risks analysis
por: Bartlett, Jonathan W., et al.
Publicado: (2016)

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool
por: Phillips, Kelly-Anne, et al.
Publicado: (2019)

The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations
por: Terry, Mary Beth, et al.
Publicado: (2019)

Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
por: Hopper, John L., et al.
Publicado: (2018)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer
por: Houghton, Lauren C., et al.
Publicado: (2018)

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

Competing risks models and time-dependent covariates
por: Barnett, Adrian, et al.
Publicado: (2008)

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits
por: Schrijver, Lieske H, et al.
Publicado: (2022)

A review of the use of time‐varying covariates in the Fine‐Gray subdistribution hazard competing risk regression model
por: Austin, Peter C., et al.
Publicado: (2019)

Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)
por: Ye, Zhoufeng, et al.
Publicado: (2022)

Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
por: Kehm, Rebecca D., et al.
Publicado: (2019)

Pubertal development in girls by breast cancer family history: the LEGACY girls cohort
por: Terry, Mary Beth, et al.
Publicado: (2017)

Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer
por: Houghton, Lauren C., et al.
Publicado: (2019)

Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)
por: Zeinomar, Nur, et al.
Publicado: (2019)

Expression variation and covariation impair analog and enable binary signaling control
por: Kovary, Kyle M, et al.
Publicado: (2018)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
por: Li, Shuai, et al.
Publicado: (2022)

Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk
por: Kehm, Rebecca D, et al.
Publicado: (2021)

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
por: Kast, Karin, et al.
Publicado: (2023)

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
por: Schrijver, Lieske H, et al.
Publicado: (2018)

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
por: Dite, G S, et al.
Publicado: (2010)

Women's thoughts on receiving and sharing genetic information: Considerations for genetic counseling
por: Pfledderer, Christopher D., et al.
Publicado: (2022)

Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer
por: Wong, Ee Ming, et al.
Publicado: (2020)

Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information
por: Himes, Deborah O., et al.
Publicado: (2015)

Cholesterol and Hypertension Treatment Improve Coronary Risk Prediction but Not Time-Dependent Covariates or Competing Risks
por: Subirana, Isaac, et al.
Publicado: (2022)

Competing Risks Data Analysis with High-dimensional Covariates: An Application in Bladder Cancer
por: Tapak, Leili, et al.
Publicado: (2015)

Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk
por: Quante, Anne S., et al.
Publicado: (2015)

Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer
por: Shen, Jing, et al.
Publicado: (2017)

Risk of Mortality Prediction Involving Time-Varying Covariates for Patients with Heart Failure Using Deep Learning
por: Nakamura, Keijiro, et al.
Publicado: (2022)

Using Time-Varying Covariates in Multilevel Growth Models
por: McCoach, D. Betsy, et al.
Publicado: (2010)

Simulation shows undesirable results for competing risks analysis with time-dependent covariates for clinical outcomes
por: Poguntke, Inga, et al.
Publicado: (2018)

Marginal models in analysis of correlated binary data with time dependent covariates
por: Wilson, Jeffrey R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i0o9lbqmnvp4em7kj7c242u9ea